Progressive Multifocal Leukoencephalopathy in a Patient With Progressive Multiple Sclerosis Treated With Ocrelizumab Monotherapy

Case report details finding of progressive multifocal leukoencephalopathy in a 78-year-old treated with ocrelizumab for 2 years. Authors highlight the importance of risk/benefit discussion for this drug, especially in those at higher risk for infections such as the elderly.

Source:

JAMA Neurology